Antibody Drugs Could Be Next COVID-19 Milestone

DARPA Saw The Pandemic Coming – Can AbCellera Investment Pay Off?

 
• By Andrew McConaghie

Working with the US agency for two years, AbCellera was primed to respond, and is competing with Vir and Regeneron to bring a COVID-19 therapy to patients before the end of 2020.

Hudson_Park_NY
New York, 2 May 2020: Social distancing has helped flatten the curve, but can't go on indefinitely. Antibody drugs could arrive by late 2020, ahead of vaccines to help tackle COVID-19.

More from Clinical Trials

More from R&D